Showing results 2 to 3 of 3
< previous
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
Biomarker analyses of Asian women with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC) receiving ribociclib (RIB) + endocrine therapy (ET) Proceeding/Conference:ESMO (European Society for Medical On) ASIA 2018 | 2018 | 36 | ||
Upregulation of Immune Response Biomarkers by Ribociclib Plus Endocrine Therapy in Paired Tumor Samples From Phase I Studies Proceeding/Conference:San Antonio Breast Cancer Symposium 2021 | 2021 | 8 |